The purpose of the protocol is to assess the rate of castration resistance, disease progression and overall survival over a 3-year period post-androgen deprivation therapy (ADT) induction in a study cohort of patients with advanced disease.
Study Type
OBSERVATIONAL
Enrollment
180
Castration-resistant prostate cancer (CRPC)
Time frame: Over a 3-year period post-androgen deprivation therapy induction
Disease progression (DP) rate post-androgen deprivation therapy induction
Time frame: Over a 3-year period post-androgen deprivation therapy induction
Overall survival
Time frame: 3-years post-androgen deprivation therapy induction
Serum prostate specific antigen
Time frame: Over a 3-year period post-androgen deprivation therapy induction
Serum testosterone
Time frame: Over a 3-year period post-androgen deprivation therapy induction
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Fredericia Sygehus
Fredericia, Denmark
Frederiksbergs Hospital
Frederiksberg, Denmark
Herlev University Hospital
Herlev, Denmark
Odense Universitets Hospital
Odense, Denmark
Clinique Rhône Durance
Avignon, France
Hôpital Pellegrin
Bordeaux, France
CHU Henri Mondor
Créteil, France
Chru Lille
Lille, France
Hôpital Nord
Marseille, France
Clinique Beau Soleil
Montpellier, France
...and 25 more locations